Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $83.03 USD
Change Today -0.53 / -0.64%
Volume 66.6K
DXCM On Other Exchanges
Symbol
Exchange
DXCM is not on other exchanges.
As of 10:41 AM 07/30/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Terrance H. Gregg

Executive Chairman, DexCom, Inc.
AgeTotal Calculated CompensationThis person is connected to 16 board members in 2 different organizations across 8 different industries.

See Board Relationships
66$10,129,811
As of Fiscal Year 2014

Background*

Mr. Terrance H. Gregg, also known as Terry has been a Special Venture Partner at Galen Partners since 2002. Mr. Gregg served as the Chief Executive Officer of DexCom, Inc. since June 2007. He served as the President of DexCom, Inc. from June 2007 to June 1, 2011. He served as the Chief Executive Officer and President of Vasogen, Inc. from March 7, 2007 to June 20, 2007. He served as the Chief Operating Officer of Medtronic MiniMed, Inc. (also known as MiniMed, Inc.) ...

Read Full Background

Corporate Headquarters*

6340 Sequence Drive
San Diego, California 92121

United States

Phone: 858-200-0200
Fax: --

Board Members Memberships*

Executive Chairman
2005-Present
Executive Chairman

Education*

BS 1971
Colorado State University

Other Affiliations*

Annual Compensation*

Salary$420,000
Total Annual Compensation$420,000

Stock Options*

Restricted Stock Awards$8,668,810
All Other Compensation$33,001
Exercised Options993,497
Exercised Options Value$37,861,513
Exercisable Options578,393
Exercisable Options Value$28,252,046
Total Value of Options$66,113,559
Total Number of Options1,571,890

Total Compensation*

Total Annual Cash Compensation$1,461,001
Total Short Term Compensation$420,000
Other Long Term Compensation$8,701,811
Total Calculated Compensation$10,129,811
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
DXCM:US $83.05 USD -0.51

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Justin C. Dearborn Chief Executive Officer, President, Corporate Secretary, Director, Member of Executive Committee and Chief Executive Officer of Merge DNA
Merge Healthcare Incorporated
$400.0K
Miles D. White Chairman, Chief Executive Officer and Chairman of Executive Committee
Abbott Laboratories
$2.0M
Patrick J. Sullivan Chief Executive Officer, President and Director
Insulet Corporation
$182.5K
Philip Bowman Chief Executive Officer and Executive Director
Smiths Group plc
1.5M GBP
Kim D. Blickenstaff Chief Executive Officer, President and Director
Tandem Diabetes Care, Inc.
$532.7K
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact DEXCOM INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.